Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0235131396957123 -0.0387275242047027 -0.0168464730290457 0.0583402489626556
Stock impact report

CEL-SCI Corporation Releases Letter to Shareholders

Cel-Sci Corporation (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
Company Research Source: Business Wire
VIENNA, Va.--(BUSINESS WIRE)-- The following letter was sent by CEL-SCI Corporation (NYSE American: CVM) to its shareholders: Dear CEL-SCI Shareholders: The first 4 months of this year have already been very positive for us. Our Phase 3 head and neck cancer study is continuing and we are moving forward with our Rheumatoid Arthritis product development. Since January 1, we have received about $9.6 million from the conversion of warrants to finance our ongoing projects. We believe the following developments with regard to the Multikine* Phase 3 trial have contributed to additional investments in our Company: Length of Phase 3 study could be a sign of Multikine’s efficacy:We have not yet hit the primary endpoint of our 928 patient Phase 3 study with our investigational cancer immunotherapy drug Multikine. That endpoint will be reached when 298 events (deaths) hav Show less Read more
Impact Snapshot
Event Time:
CVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CVM alerts

from News Quantified
Opt-in for
CVM alerts

from News Quantified